Her primary areas of investigation include Breast cancer, Internal medicine, Oncology, Genome-wide association study and Genetics. Her research integrates issues of Single-nucleotide polymorphism, Genotype and Genetic predisposition in her study of Breast cancer. Her Internal medicine study integrates concerns from other disciplines, such as Three prime untranslated region, Endocrinology and Pathology.
Her work carried out in the field of Oncology brings together such families of science as Cancer screening, Metastatic breast cancer, microRNA, Triple-negative breast cancer and Prostate cancer. Her Genome-wide association study research is multidisciplinary, relying on both Mendelian randomization and Disease. Her work on Genetics is being expanded to include thematically relevant topics such as Cancer research.
Barbara Burwinkel spends much of her time researching Breast cancer, Internal medicine, Oncology, Genetics and Single-nucleotide polymorphism. Her study in Breast cancer is interdisciplinary in nature, drawing from both Odds ratio, Genome-wide association study and Genotype. Her research in Genome-wide association study intersects with topics in Genetic predisposition, Medical genetics, Ovarian cancer, Genetic association and Endometrial cancer.
Her Internal medicine research includes themes of Endocrinology, Bioinformatics and Pathology. Her Oncology research is multidisciplinary, incorporating perspectives in DNA methylation, Metastatic breast cancer, Proportional hazards model, Colorectal cancer and Cohort. Her Single-nucleotide polymorphism study incorporates themes from Haplotype and Candidate gene.
Barbara Burwinkel mostly deals with Breast cancer, Internal medicine, Oncology, Cancer research and DNA methylation. Her Breast cancer research integrates issues from Genome-wide association study and Medical genetics. She has included themes like Endometrial cancer and Disease in her Genome-wide association study study.
Her biological study deals with issues like Single-nucleotide polymorphism, which deal with fields such as Logistic regression. Her Oncology research incorporates themes from Germline mutation, Prostate, Ovarian cancer, Prostate cancer and Cohort. Her studies in DNA methylation integrate themes in fields like Metabolite, Methylation and Epigenetics.
Breast cancer, Internal medicine, Oncology, Genome-wide association study and Expression quantitative trait loci are her primary areas of study. Barbara Burwinkel has researched Breast cancer in several fields, including CHEK2 and Risk factor. Her study on Internal medicine is mostly dedicated to connecting different topics, such as DNA methylation.
Her Oncology study combines topics in areas such as Metastatic breast cancer and Real-time polymerase chain reaction. Barbara Burwinkel combines subjects such as Endometrial cancer, Disease and Medical genetics with her study of Genome-wide association study. Her Expression quantitative trait loci study is concerned with the larger field of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Characterization of extracellular circulating microRNA
Andrey Turchinovich;Ludmila Weiz;Anne Langheinz;Barbara Burwinkel.
Nucleic Acids Research (2011)
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease
Stefan Stein;Marion G. Ott;Stephan Schultze-Strasser;Anna Jauch.
Nature Medicine (2010)
Tobacco-smoking-related differential DNA methylation: 27K discovery and replication.
Lutz P. Breitling;Rongxi Yang;Rongxi Yang;Bernhard Korn;Barbara Burwinkel;Barbara Burwinkel.
American Journal of Human Genetics (2011)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley.
Nature Genetics (2013)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
Shahana Ahmed;Gilles Thomas;Maya Ghoussaini;Catherine S. Healey.
Nature Genetics (2009)
Extracellular miRNAs: the mystery of their origin and function.
Andrey Turchinovich;Ludmila Weiz;Barbara Burwinkel.
Trends in Biochemical Sciences (2012)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Nasim Mavaddat;Paul D.P. Pharoah;Kyriaki Michailidou;Jonathan Tyrer.
Journal of the National Cancer Institute (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: